Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Heska Corporation stock

Own Heska Corporation stock in just a few minutes.

Heska Corporation is a diagnostics & research business based in the US. Heska Corporation shares (HSKA) are listed on the NASDAQ and all prices are listed in US Dollars. Heska Corporation employs 602 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Heska Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSKA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Heska Corporation share price

Use our graph to track the performance of HSKA stocks over time.

Heska Corporation shares at a glance

Information last updated 2021-04-29.
52-week range$66.45 - $217.17
50-day moving average $176.79
200-day moving average $156.39
Wall St. target price$208.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.47

Buy Heska Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Heska Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Heska Corporation under- or over-valued?

Valuing Heska Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Heska Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Heska Corporation's PEG ratio

Heska Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Heska Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Heska Corporation's EBITDA

Heska Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11 million.

The EBITDA is a measure of a Heska Corporation's overall financial performance and is widely used to measure a its profitability.

Heska Corporation financials

Revenue TTM $197.3 million
Operating margin TTM 0.66%
Gross profit TTM $81.3 million
Return on assets TTM 0.25%
Return on equity TTM -6.68%
Profit margin -7.3%
Book value $30.29
Market capitalisation $1.9 billion

TTM: trailing 12 months

Shorting Heska Corporation shares

There are currently 307,875 Heska Corporation shares held short by investors – that's known as Heska Corporation's "short interest". This figure is 10.8% down from 345,129 last month.

There are a few different ways that this level of interest in shorting Heska Corporation shares can be evaluated.

Heska Corporation's "short interest ratio" (SIR)

Heska Corporation's "short interest ratio" (SIR) is the quantity of Heska Corporation shares currently shorted divided by the average quantity of Heska Corporation shares traded daily (recently around 68264.966740577). Heska Corporation's SIR currently stands at 4.51. In other words for every 100,000 Heska Corporation shares traded daily on the market, roughly 4510 shares are currently held short.

However Heska Corporation's short interest can also be evaluated against the total number of Heska Corporation shares, or, against the total number of tradable Heska Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Heska Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Heska Corporation shares in existence, roughly 30 shares are currently held short) or 0.0424% of the tradable shares (for every 100,000 tradable Heska Corporation shares, roughly 42 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Heska Corporation.

Find out more about how you can short Heska Corporation stock.

Heska Corporation share dividends

We're not expecting Heska Corporation to pay a dividend over the next 12 months.

Have Heska Corporation's shares ever split?

Heska Corporation's shares were split on a 1:10 basis on 29 December 2010. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heska Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Heska Corporation shares which in turn could have impacted Heska Corporation's share price.

Heska Corporation share price volatility

Over the last 12 months, Heska Corporation's shares have ranged in value from as little as $66.45 up to $217.17. A popular way to gauge a stock's volatility is its "beta".

HSKA.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heska Corporation's is 1.6922. This would suggest that Heska Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Heska Corporation overview

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site